Treatment of Relapsed/Refractory Multiple Myeloma With t 11;14 Translocation Using BGB-11417 With Dexamethasone; Also Using BGB-11417 in Combination With Dexamethasone and Carfilzomib.

• Status: Recruiting
• Trial end date: 2025-09-01

Summary

Study consists of two parts, a part 1 dose escalation and a part 2 (cohort expansion in combination with dexamethasone and carfilzomib intravenously across two cohorts)

• Phase: Phase 1/Phase 2

Details

• Lead Sponsor: BeiGene
• Treatments: BB 1101; Dexamethasone; Dexamethasone acetate